GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis

Your Location：

Home >

Browse articles >

COMMENTARY | Updated：2025-12-13

- GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis
- GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis
- “在xxx领域，xx专家取得了重大进展。他们建立了xx体系/探索了xx主题/验证了xx猜想，为解决xx问题提供了解决方案，为xx的未来研究铺平了道路。”
- MMR 2024年11卷第6期页码：963-964
- Affiliations：
  
  Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, USA
- Author bio：
  
  *l0gobe01@louisville.edu
- Funds：
- DOI：10.1186/s40779-023-00507-2
  中图分类号：
- 纸质出版：2024-12
- Accepted：
Scan QR Code
GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis[J]. MMR, 2024,11(6):963-964.

Cite this article as: Gobejishvili L. GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis. Mil Med Res. 2024;11(1):4.
GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis[J]. MMR, 2024,11(6):963-964. DOI： 10.1186/s40779-023-00507-2.

Cite this article as: Gobejishvili L. GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis. Mil Med Res. 2024;11(1):4. DOI： 10.1186/s40779-023-00507-2.

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia

Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases

The emerging role of Panx1 as a potential therapeutic target for chronic pain

P. gingivalis in oral-prostate axis exacerbates benign prostatic hyperplasia via IL-6/IL-6R pathway

Exosomal mediators in sepsis and inflammatory organ injury: unraveling the role of exosomes in intercellular crosstalk and organ dysfunction